Real World Evidence Market
- 2026 年市場規模
- USD 4,625.8 Mn
- 2033 年預估規模
- USD 10,420.7 Mn
- 年複合成長率 CAGR
- 12.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
完整報告名稱與涵蓋範圍
Real World Evidence Market, By Component (Data Sets, Analytics Services, Software and Platforms, Others), By Data Source (Electronic Health Records (EHRs), Claims and Billing Data, Clinical Registries, Pharmacy and Prescription Data, Patient-Generated Health Data, Wearable and Digital Health Data, Others), By Application (Drug Development and Clinical Trials, Regulatory Decision-Making, Post-Market Surveillance, Comparative Effectiveness Research, Health Economics and Outcomes Research, Safety and Risk Management, Market Access and Reimbursement, Others), By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurology, Immunology, Infectious Diseases, Respiratory Diseases, Rare Diseases, Others), By End User (Pharmaceutical and Biotechnology Companies, Healthcare Providers, Contract Research Organizations (CROs), Regulatory Authorities, Payers and Health Insurance Providers, Academic and Research Institutions, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global real world evidence market is estimated to be valued at USD 4,625.8 Mn in 2026 and is expected to reach USD 10,420.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033. Real World Evidence (RWE) is clinical evidence that comes from analyzing real world data (RWD) gathered outside of traditional randomized controlled trials such as electronic health records, claims data, registries, patient-generated data, and digital health technologies. The global RWE market is changing healthcare and life sciences by providing insights into the performance of medical products across different patient populations and in routine clinical settings.
The increasing adoption of value-based care and precision medicine is strengthening the strategic role of RWE in clinical development, regulatory decision making and post-market surveillance. Regulatory agencies such as the U.S. FDA and European Medicines Agency (EMA) are increasingly embracing RWE in drug development and regulatory systems, enabling its use in approvals, label expansions and post-approval evidence generation.
Market Dynamics
The global real world evidence market is driven by the increasing use of electronic health records (EHRs) and health information technologies, the increasing demand for evidence on comparative effectiveness and cost-efficiency, and the growing prevalence of chronic diseases that require continuous tracking of outcomes. The increasing integration of artificial intelligence (AI) and machine learning (ML) is enhancing the analysis of large and complex real-world datasets, while supportive regulations are promoting the use of RWE in drug development and healthcare decision-making.
However, a number of constraints are present in the market, such as data privacy and security needs, inconsistent data quality, standardization and interoperability alongside a shortage of skilled RWE professionals. Nevertheless, significant opportunities exist with the increasing use of RWE in medical device evaluation, health technology assessment and personalized medicine and healthcare digitization across Asia-Pacific, Latin America and the Middle East creating new data sources and market opportunities.
Key Features of the Study
• This report provides in-depth analysis of the global real world evidence market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global real world evidence market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Komodo Health, Inc., Merative, Optum, Inc., ICON plc, Syneos Health, Inc., Parexel International Corporation, Oracle Corporation, SAS Institute Inc., Aetion, Inc., and TriNetX, LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global real world evidence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global real world evidence market
Market Segmentation
• Component Insights (Revenue, USD Mn, 2021 - 2033)
o Data Sets
o Analytics Services
o Software and Platforms
o Others
• Data Source Insights (Revenue, USD Mn, 2021 - 2033)
o Electronic Health Records (EHRs)
o Claims and Billing Data
o Clinical Registries
o Pharmacy and Prescription Data
o Patient-Generated Health Data
o Wearable and Digital Health Data
o Others
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Drug Development and Clinical Trials
o Regulatory Decision-Making
o Post-Market Surveillance
o Comparative Effectiveness Research
o Health Economics and Outcomes Research
o Safety and Risk Management
o Market Access and Reimbursement
o Others
• Therapeutic Area Insights (Revenue, USD Mn, 2021 - 2033)
o Oncology
o Cardiovascular Diseases
o Neurology
o Immunology
o Infectious Diseases
o Respiratory Diseases
o Rare Diseases
o Others
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Pharmaceutical and Biotechnology Companies
o Healthcare Providers
o Contract Research Organizations (CROs)
o Regulatory Authorities
o Payers and Health Insurance Providers
o Academic and Research Institutions
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Komodo Health, Inc.
o Merative
o Optum, Inc.
o ICON plc
o Syneos Health, Inc.
o Parexel International Corporation
o Oracle Corporation
o SAS Institute Inc.
o Aetion, Inc.
o TriNetX, LLC
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Real World Evidence Market, By Component
Global Real World Evidence Market, By Data Source
Global Real World Evidence Market, By Application
Global Real World Evidence Market, By Therapeutic Area
Global Real World Evidence Market, By End User
Global Real World Evidence Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Component Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Industry Trends
4. Global Real World Evidence Market, By Component, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Data Sets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Analytics Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Software and Platforms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Real World Evidence Market, By Data Source, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Electronic Health Records (EHRs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Claims and Billing Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Clinical Registries
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Pharmacy and Prescription Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Benign Prostatic Hyperplasia (BPH) Patient-Generated Health Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Wearable and Digital Health Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Real World Evidence Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Drug Development and Clinical Trials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Regulatory Decision-Making
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Post-Market Surveillance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Comparative Effectiveness Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Health Economics and Outcomes Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Safety and Risk Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Market Access and Reimbursement
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Real World Evidence Market, By Therapeutic Area, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Immunology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Respiratory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Rare Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Real World Evidence Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Pharmaceutical and Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Healthcare Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Contract Research Organizations (CROs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Regulatory Authorities
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Payers and Health Insurance Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Academic and Research Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Real World Evidence Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Component, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Data Source, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
10. Competitive Landscape
o Komodo Health, Inc.
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o Merative
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o Optum, Inc.
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o ICON plc
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o Syneos Health, Inc.
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o Parexel International Corporation
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o Oracle Corporation
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o SAS Institute Inc.
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o Aetion, Inc.
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
o TriNetX, LLC
Company Highlights
Component Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
12. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Real World Evidence Market' - Global forecast to 2033
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們